Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.

Akhtar Ms,Kousar F,Masood M,Fatimi S,Kokab

Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.

2010

Akhtar Ms
Kousar F
Masood M
Fatimi S
Kokab

Objective: To compare the results of patients with locally advanced breast cancer receiving two different regimens Fluorouracil, Doxorubicin and Cyclophosphamide (FAC) and Paclitaxel and Carboplatin. Study Design: Comparative study.

Keywords:

Fluorouracil
Neoadjuvant therapy
Carboplatin
Doxorubicin
Breast cancer
Paclitaxel
Cancer research
Surgery
Oncology
Chemotherapy
Internal medicine
Cyclophosphamide
Medicine
combination chemotherapy
Performance status
Mucositis
Regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations